Sartorius Stock - analyst consensus and valuation snapshot
21.06.2026 - 11:03:14 | ad-hoc-news.de
Edited by ad hoc news Analyst & Consensus Desk. Verified prior to publication on 06/21/2026, 11:02 CET. Details in the imprint.
Sartorius (DE0006292006) remains a closely watched German laboratory and bioprocess equipment specialist. In the absence of fresh ad-hoc headlines today, the stock is mainly driven by existing analyst estimates and the broader view on demand in biopharma equipment.
All news and key data on Sartorius stock
Background articles, regulatory filings and price data provide additional context for Sartorius as a leading supplier to the biopharmaceutical industry.
What analysts currently project
Without new company-specific headlines this weekend, investor attention stays on the existing analyst consensus for Sartorius, particularly earnings expectations and valuation multiples compared with European life-science peers.
Market data providers such as MarketScreener and other analyst aggregators show a mix of Buy, Hold and Sell ratings, reflecting the still-uncertain pace of recovery in bioprocess equipment orders.
How consensus shapes the narrative
On Sundays, when markets are closed and no trading data updates in real time, consensus estimates and published research from banks such as Deutsche Bank, UBS or Berenberg often guide expectations for the next trading week.
Investors tend to compare Sartorius with other tools and bioprocessing names, looking at metrics like forward price-to-earnings ratios and expected mid-term revenue growth in biopharma equipment demand.
How the company makes money
Sartorius generates most of its revenue from laboratory instruments and bioprocess solutions for the biopharmaceutical industry. This includes single-use bioreactors, filtration systems and lab balances that support drug discovery and large-scale biologics manufacturing.
Where the stock trades today
The shares of Sartorius (DE0006292006) are listed in Germany; as markets are closed over the weekend, the latest available Xetra price and market data from the last trading session remain the reference point until trading resumes.
Key facts on Sartorius stock
- Company: Sartorius AG
- ISIN: DE0006292006
- WKN: 716563
- Ticker: SRT3
- Venue: Xetra
- Sector / Industry: Health Care / Life Science Tools
- Index membership: DAX
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
